A Study of the Efficacy and Safety of GB-0998 in Patients With Unexplained Recurrent Miscarriage

NCT02184741 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
99
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Japan Blood Products Organization